{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:56:12Z","timestamp":1790898972536,"version":"4.1.0"},"reference-count":173,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.cytogfr.2012.06.003","type":"journal-article","created":{"date-parts":[[2012,6,29]],"date-time":"2012-06-29T22:00:26Z","timestamp":1341007226000},"page":"69-81","source":"Crossref","is-referenced-by-count":28,"title":["The \u201cbone morphogenic proteins\u201d pathways in bone and joint diseases: Translational perspectives from physiopathology to therapeutic targets"],"prefix":"10.1016","volume":"24","author":[{"given":"Emmanuel","family":"Biver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Hardouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Caverzasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2012.06.003_bib0005","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/mrd.1080320212","article-title":"The bone morphogenetic protein family and osteogenesis","volume":"32","author":"Wozney","year":"1992","journal-title":"Molecular Reproduction and Development"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/cr.2008.302","article-title":"Signaling cross-talk between TGF-beta\/BMP and other pathways","volume":"19","author":"Guo","year":"2009","journal-title":"Cell Research"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0015","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1359\/jbmr.1997.12.3.343","article-title":"Bone morphogenetic protein: the molecularization of skeletal system development","volume":"12","author":"Urist","year":"1997","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1196\/annals.1346.006","article-title":"BMP signaling and skeletogenesis","volume":"1068","author":"Li","year":"2006","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0025","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1006\/bbrc.1996.0411","article-title":"Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2\/PA6","volume":"220","author":"Yamaguchi","year":"1996","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0030","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/jcb.20211","article-title":"Multiple functions of BMPs in chondrogenesis","volume":"93","author":"Yoon","year":"2004","journal-title":"Journal of Cellular Biochemistry"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0035","doi-asserted-by":"crossref","first-page":"12670","DOI":"10.1073\/pnas.0906266106","article-title":"BMP signaling pathway is required for commitment of C3H10T1\/2 pluripotent stem cells to the adipocyte lineage","volume":"106","author":"Huang","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0040","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1089\/scd.2008.0130","article-title":"A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells","volume":"18","author":"Kang","year":"2009","journal-title":"Stem Cells and Development"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0045","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1210\/er.2002-0023","article-title":"Bone morphogenetic proteins, their antagonists, and the skeleton","volume":"24","author":"Canalis","year":"2003","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0050","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/08977190412331279890","article-title":"Bone morphogenetic proteins","volume":"22","author":"Chen","year":"2004","journal-title":"Growth Factors"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0055","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.cytogfr.2010.06.001","article-title":"BMP signaling in vascular development and disease","volume":"21","author":"Lowery","year":"2010","journal-title":"Cytokine and Growth Factor Reviews"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0060","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S8756-3282(99)00113-1","article-title":"Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteins","volume":"25","author":"Miyazono","year":"1999","journal-title":"Bone"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0065","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1074\/jbc.M102750200","article-title":"The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways","volume":"277","author":"Nohe","year":"2002","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0070","doi-asserted-by":"crossref","first-page":"20948","DOI":"10.1074\/jbc.M800850200","article-title":"BMP-2\/4 and BMP-6\/7 differentially utilize cell surface receptors to induce osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells","volume":"283","author":"Lavery","year":"2008","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0075","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1002\/jcp.23032","article-title":"Initiation of BMP2 signaling in domains on the plasma membrane","volume":"227","author":"Bonor","year":"2012","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0080","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1126\/science.1071809","article-title":"Signal transduction by the TGF-beta superfamily","volume":"296","author":"Attisano","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0085","doi-asserted-by":"crossref","first-page":"15514","DOI":"10.1074\/jbc.M200794200","article-title":"Signal transductions induced by bone morphogenetic protein-2 and transforming growth factor-beta in normal human osteoblastic cells","volume":"277","author":"Lai","year":"2002","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0090","doi-asserted-by":"crossref","first-page":"31353","DOI":"10.1074\/jbc.M503845200","article-title":"BMP-2 and insulin-like growth factor-I mediate Osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways","volume":"280","author":"Celil","year":"2005","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0095","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.coph.2007.01.003","article-title":"Potential drug targets within bone morphogenetic protein signaling pathways","volume":"7","author":"Gazzerro","year":"2007","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0100","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1172\/JCI3459","article-title":"Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts","volume":"102","author":"Gazzerro","year":"1998","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0105","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1210\/en.141.12.4558","article-title":"Bone morphogenetic proteins induce gremlin, a protein that limits their activity in osteoblasts","volume":"141","author":"Pereira","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0110","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1210\/en.2004-0766","article-title":"Skeletal overexpression of gremlin impairs bone formation and causes osteopenia","volume":"146","author":"Gazzerro","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0115","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","article-title":"Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling","volume":"280","author":"Li","year":"2005","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0120","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/46794","article-title":"Silencing of TGF-beta signalling by the pseudoreceptor BAMBI","volume":"401","author":"Onichtchouk","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0125","doi-asserted-by":"crossref","first-page":"6075","DOI":"10.1074\/jbc.275.9.6075","article-title":"Smad6 is a Smad1\/5-induced smad inhibitor. Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter","volume":"275","author":"Ishida","year":"2000","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/1874467211104020141","article-title":"Inhibitory Smad7: emerging roles in health and disease","volume":"4","author":"Briones-Orta","year":"2011","journal-title":"Current Molecular Pharmacology"},{"issue":"Suppl. 3","key":"10.1016\/j.cytogfr.2012.06.003_bib0135","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2106\/00004623-200300003-00008","article-title":"Negative regulation of BMP signaling by the ski oncoprotein","volume":"85-A","author":"Luo","year":"2003","journal-title":"Journal of Bone and Joint Surgery"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0140","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0092-8674(00)00211-7","article-title":"Negative regulation of BMP\/Smad signaling by Tob in osteoblasts","volume":"103","author":"Yoshida","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0145","doi-asserted-by":"crossref","first-page":"10294","DOI":"10.1073\/pnas.0506945103","article-title":"Nanog binds to Smad1 and blocks bone morphogenetic protein-induced differentiation of embryonic stem cells","volume":"103","author":"Suzuki","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0150","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1074\/jbc.M509430200","article-title":"Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts","volume":"281","author":"Kaneki","year":"2006","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2005.06.017","article-title":"The BMP signaling and in vivo bone formation","volume":"357","author":"Cao","year":"2005","journal-title":"Gene"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0160","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1593","article-title":"Skeletal remodeling in health and disease","volume":"13","author":"Zaidi","year":"2007","journal-title":"Nature Medicine"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0165","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0092-8674(01)00622-5","article-title":"The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation","volume":"108","author":"Nakashima","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0170","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/jcb.10369","article-title":"Regulation of the osteoblast-specific transcription factor, Runx2: responsiveness to multiple signal transduction pathways","volume":"88","author":"Franceschi","year":"2003","journal-title":"Journal of Cellular Biochemistry"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0175","doi-asserted-by":"crossref","first-page":"34387","DOI":"10.1074\/jbc.M211386200","article-title":"BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression","volume":"278","author":"Lee","year":"2003","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0870","article-title":"The role of BMPs in bone anabolism and their potential targets SOST and DKK1","author":"Kamiya","year":"2011","journal-title":"Current Molecular Pharmacology"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0185","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.bbrc.2011.09.060","article-title":"Loss-of-function of ACVR1 in osteoblasts increases bone mass and activates canonical Wnt signaling through suppression of Wnt inhibitors SOST and DKK1","volume":"414","author":"Kamiya","year":"2011","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0190","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00441-010-1052-y","article-title":"Bone morphogenetic protein 2 enhances mouse osteoclast differentiation via increased levels of receptor activator of NF-kappaB ligand expression in osteoblasts","volume":"342","author":"Tachi","year":"2010","journal-title":"Cell and Tissue Research"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0195","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2443.2008.01258.x","article-title":"Bone morphogenetic protein-2 enhances Wnt\/beta-catenin signaling-induced osteoprotegerin expression","volume":"14","author":"Sato","year":"2009","journal-title":"Genes to Cells"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0200","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2741\/3673","article-title":"Regulatory mechanism of osteoclastogenesis by RANKL and Wnt signals","volume":"16","author":"Takahashi","year":"2011","journal-title":"Frontiers in Bioscience"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0205","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1182\/blood-2008-01-132134","article-title":"Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma","volume":"112","author":"Qiang","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0210","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1476-4598-6-71","article-title":"Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF","volume":"6","author":"Fujita","year":"2007","journal-title":"Molecular Cancer"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0215","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/jcb.22462","article-title":"Bone morphogenic protein 2 directly enhances differentiation of murine osteoclast precursors","volume":"109","author":"Jensen","year":"2010","journal-title":"Journal of Cellular Biochemistry"},{"issue":"Suppl. 4","key":"10.1016\/j.cytogfr.2012.06.003_bib0220","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0020-1383(08)70008-1","article-title":"Biological enhancement of bone healing with Bone Morphogenetic Protein-7 at the clinical setting of pelvic girdle non-unions","volume":"38","author":"Giannoudis","year":"2007","journal-title":"Injury"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0225","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cytogfr.2009.10.006","article-title":"The FOP metamorphogene encodes a novel type I receptor that dysregulates BMP signaling","volume":"20","author":"Kaplan","year":"2009","journal-title":"Cytokine and Growth Factor Reviews"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0230","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1359\/jbmr.091110","article-title":"ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formation","volume":"25","author":"van Dinther","year":"2010","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0875","doi-asserted-by":"crossref","DOI":"10.1002\/jbmr.1637","article-title":"An Acvr1 R206H knock-in mouse has fibrodysplasia ossificans progressiva","author":"Chakkalakal","year":"2012","journal-title":"Journal of Bone Minerals Research"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0240","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1749-6632.2011.06195.x","article-title":"Fibrodysplasia ossificans progressiva: a blueprint for metamorphosis","volume":"1237","author":"Kaplan","year":"2011","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0245","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/jor.21354","article-title":"Cytokine expression in muscle following traumatic injury","volume":"29","author":"Jackson","year":"2011","journal-title":"Journal of Orthopaedic Research"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0250","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/rheumatology\/40.10.1163","article-title":"Involvement of bone morphogenic protein-2 (BMP-2) in the pathological ossification process of the spinal ligament","volume":"40","author":"Tanaka","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0255","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1371\/journal.pgen.0020216","article-title":"Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis","volume":"2","author":"Bandyopadhyay","year":"2006","journal-title":"PLoS Genet"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0260","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/(SICI)1520-6408(1998)22:4<321::AID-DVG3>3.0.CO;2-8","article-title":"Mice lacking Bmp6 function","volume":"22","author":"Solloway","year":"1998","journal-title":"Developmental Genetics"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0265","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/jor.20996","article-title":"Conditional deletion of BMP7 from the limb skeleton does not affect bone formation or fracture repair","volume":"28","author":"Tsuji","year":"2010","journal-title":"Journal of Orthopaedic Research"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0270","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/83810","article-title":"Bone morphogenetic protein-3 is a negative regulator of bone density","volume":"27","author":"Daluiski","year":"2001","journal-title":"Nature Genetics"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0275","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1210\/me.2011-1168","article-title":"BMP3 suppresses osteoblast differentiation of bone marrow stromal cells via interaction with Acvr2b","volume":"26","author":"Kokabu","year":"2012","journal-title":"Molecular Endocrinology"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0280","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1210\/en.2002-220918","article-title":"Skeletal overexpression of noggin results in osteopenia and reduced bone formation","volume":"144","author":"Devlin","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0285","doi-asserted-by":"crossref","first-page":"31549","DOI":"10.1074\/jbc.M701317200","article-title":"Conditional deletion of gremlin causes a transient increase in bone formation and bone mass","volume":"282","author":"Gazzerro","year":"2007","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0290","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/(SICI)1097-0177(199601)205:1<13::AID-AJA2>3.0.CO;2-8","article-title":"Selective expression of a ski transgene affects IIb fast muscles and skeletal structure","volume":"205","author":"Lana","year":"1996","journal-title":"Developmental Dynamics"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0295","doi-asserted-by":"crossref","first-page":"12854","DOI":"10.1074\/jbc.M313294200","article-title":"Smurf1 inhibits osteoblast differentiation and bone formation in vitro and in vivo","volume":"279","author":"Zhao","year":"2004","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0300","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cell.2005.01.035","article-title":"Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation","volume":"121","author":"Yamashita","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0305","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1359\/jbmr.080809","article-title":"Disruption of BMP signaling in osteoblasts through type IA receptor (BMPRIA) increases bone mass","volume":"23","author":"Kamiya","year":"2008","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0310","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1359\/jbmr.090806","article-title":"Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts","volume":"25","author":"Kamiya","year":"2010","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0315","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1002\/jbmr.477","article-title":"Conditional deletion of Bmpr1a in differentiated osteoclasts increases osteoblastic bone formation, increasing volume of remodeling bone in mice","volume":"26","author":"Okamoto","year":"2011","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0320","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1359\/jbmr.090507","article-title":"Enhanced osteoclastogenesis causes osteopenia in twisted gastrulation-deficient mice through increased BMP signaling","volume":"24","author":"Sotillo Rodriguez","year":"2009","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0325","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1242\/dev.127.3.621","article-title":"The type I BMP receptor BMPRIB is required for chondrogenesis in the mouse limb","volume":"127","author":"Yi","year":"2000","journal-title":"Development"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0330","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1083\/jcb.200109012","article-title":"Bone morphogenetic protein receptor signaling is necessary for normal murine postnatal bone formation","volume":"157","author":"Zhao","year":"2002","journal-title":"Journal of Cell Biology"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0335","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1749-6632.2009.05248.x","article-title":"Generation of a mouse model with expression of bone morphogenetic protein type II receptor lacking the cytoplasmic domain in osteoblasts","volume":"1192","author":"Yang","year":"2010","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0340","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.joca.2011.03.004","article-title":"Smad1 plays an essential role in bone development and postnatal bone formation","volume":"19","author":"Wang","year":"2011","journal-title":"Osteoarthritis and Cartilage"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0345","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/jcb.22586","article-title":"Smurf control in bone cells","volume":"110","author":"Xing","year":"2010","journal-title":"Journal of Cellular Biochemistry"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0350","doi-asserted-by":"crossref","first-page":"E69","DOI":"10.1371\/journal.pbio.0000069","article-title":"Linkage of osteoporosis to chromosome 20p12 and association to BMP2","volume":"1","author":"Styrkarsdottir","year":"2003","journal-title":"PLoS Biology"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0355","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2350-6-9","article-title":"Association between a variation in the phosphodiesterase 4D gene and bone mineral density","volume":"6","author":"Reneland","year":"2005","journal-title":"BMC Medical Genetics"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0360","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1359\/jbmr.060306","article-title":"BMP-2 gene polymorphisms and osteoporosis: the Rotterdam Study","volume":"21","author":"Medici","year":"2006","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0365","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.4238\/vol9-4gmr922","article-title":"Lack of effect of bone morphogenetic protein 2 and 4 gene polymorphisms on bone density in postmenopausal Turkish women","volume":"9","author":"Ozkan","year":"2010","journal-title":"Genetic and Molecular Research"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0370","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.bone.2008.12.024","article-title":"Identification and association analysis of single nucleotide polymorphisms in the human noggin (NOG) gene and osteoporosis phenotypes","volume":"44","author":"Moffett","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0375","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1359\/jbmr.2002.17.3.513","article-title":"Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing","volume":"17","author":"Cho","year":"2002","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0380","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bone.2009.10.009","article-title":"Temporal pattern of gene expression and histology of stress fracture healing","volume":"46","author":"Kidd","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0385","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2106\/JBJS.J.00795","article-title":"Temporal and spatial vascularization patterns of unions and nonunions: role of vascular endothelial growth factor and bone morphogenetic proteins","volume":"94","author":"Garcia","year":"2012","journal-title":"Journal of Bone and Joint Surgery"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0390","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1007\/s11999-009-0981-9","article-title":"Levels of expression for BMP-7 and several BMP antagonists may play an integral role in a fracture nonunion: a pilot study","volume":"467","author":"Fajardo","year":"2009","journal-title":"Clinical Orthopaedics and Related Research"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0880","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bone.2012.03.032","article-title":"Co-expression of BMPs and BMP-inhibitors in human fractures and non-unions","volume":"51","author":"Kloen","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0400","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00264-007-0422-x","article-title":"Clinical applications of BMP-7\/OP-1 in fractures, nonunions and spinal fusion","volume":"31","author":"White","year":"2007","journal-title":"International Orthopaedics"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0405","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.orthres.2004.02.013","article-title":"Expression of bone morphogenetic proteins, receptors, and tissue inhibitors in human fetal, adult, and osteoarthritic articular cartilage","volume":"22","author":"Chen","year":"2004","journal-title":"Journal of Orthopaedic Research"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0410","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1002\/art.11248","article-title":"Expression of bone morphogenetic protein 6 in healthy and osteoarthritic human articular chondrocytes and stimulation of matrix synthesis in vitro","volume":"48","author":"Bobacz","year":"2003","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0415","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S1063-4584(03)00004-9","article-title":"Localization of bone morphogenetic protein-2 in human osteoarthritic cartilage and osteophyte","volume":"11","author":"Nakase","year":"2003","journal-title":"Osteoarthritis and Cartilage"},{"issue":"Suppl. 3","key":"10.1016\/j.cytogfr.2012.06.003_bib0420","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2106\/00004623-200300003-00011","article-title":"Stimulation of BMP-2 expression by pro-inflammatory cytokines IL-1 and TNF-alpha in normal and osteoarthritic chondrocytes","volume":"85-A","author":"Fukui","year":"2003","journal-title":"Journal of Bone and Joint Surgery"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0425","doi-asserted-by":"crossref","first-page":"R139","DOI":"10.1186\/ar2029","article-title":"Activation of WNT and BMP signaling in adult human articular cartilage following mechanical injury","volume":"8","author":"Dell\u2019Accio","year":"2006","journal-title":"Arthritis Research and Therapy"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0430","doi-asserted-by":"crossref","first-page":"R102","DOI":"10.1186\/ar2305","article-title":"Elevated extracellular matrix production and degradation upon bone morphogenetic protein-2 (BMP-2) stimulation point toward a role for BMP-2 in cartilage repair and remodeling","volume":"9","author":"Blaney Davidson","year":"2007","journal-title":"Arthritis Research and Therapy"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0435","first-page":"103","article-title":"Regulation of anabolic and catabolic gene expression in normal and osteoarthritic adult human articular chondrocytes by osteogenic protein-1","volume":"22","author":"Fan","year":"2004","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0440","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1002\/art.1780391117","article-title":"Recombinant human osteogenic protein 1 is a potent stimulator of the synthesis of cartilage proteoglycans and collagens by human articular chondrocytes","volume":"39","author":"Flechtenmacher","year":"1996","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0445","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.joca.2004.01.008","article-title":"Osteogenic Protein-1 inhibits matrix depletion in a hyaluronan hexasaccharide-induced model of osteoarthritis","volume":"12","author":"Nishida","year":"2004","journal-title":"Osteoarthritis and Cartilage"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0450","doi-asserted-by":"crossref","first-page":"25386","DOI":"10.1074\/jbc.M302048200","article-title":"Inhibitory effects of insulin-like growth factor-1 and osteogenic protein-1 on fibronectin fragment- and interleukin-1beta-stimulated matrix metalloproteinase-13 expression in human chondrocytes","volume":"278","author":"Im","year":"2003","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0455","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1053\/joca.1998.0129","article-title":"Differential effects of local application of BMP-2 or TGF-beta 1 on both articular cartilage composition and osteophyte formation","volume":"6","author":"van Beuningen","year":"1998","journal-title":"Osteoarthritis and Cartilage"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0460","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1002\/art.23034","article-title":"Resemblance of osteophytes in experimental osteoarthritis to transforming growth factor beta-induced osteophytes: limited role of bone morphogenetic protein in early osteoarthritic osteophyte formation","volume":"56","author":"Blaney Davidson","year":"2007","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0465","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0736-0266(03)00055-X","article-title":"Alterations in endogenous osteogenic protein-1 with degeneration of human articular cartilage","volume":"21","author":"Merrihew","year":"2003","journal-title":"Journal of Orthopaedic Research"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0470","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.cytogfr.2011.08.001","article-title":"Bone morphogenetic protein 7: a broad-spectrum growth factor with multiple target therapeutic potency","volume":"22","author":"Boon","year":"2011","journal-title":"Cytokine and Growth Factor Reviews"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0475","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00264-009-0751-z","article-title":"Relationship of plasma and synovial fluid BMP-7 with disease severity in knee osteoarthritis patients: a pilot study","volume":"33","author":"Honsawek","year":"2009","journal-title":"International Orthopaedics"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0480","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1002\/art.20441","article-title":"Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts","volume":"50","author":"Tardif","year":"2004","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0485","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.joca.2008.06.022","article-title":"The BMP antagonists follistatin and gremlin in normal and early osteoarthritic cartilage: an immunohistochemical study","volume":"17","author":"Tardif","year":"2009","journal-title":"Osteoarthritis and Cartilage"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0490","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/art.21897","article-title":"Noggin haploinsufficiency differentially affects tissue responses in destructive and remodeling arthritis","volume":"54","author":"Lories","year":"2006","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0495","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1002\/art.20750","article-title":"Bone morphogenetic protein and transforming growth factor beta inhibitory Smads 6 and 7 are expressed in human adult normal and osteoarthritic cartilage in vivo and are differentially regulated in vitro by interleukin-1beta","volume":"50","author":"Kaiser","year":"2004","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0500","doi-asserted-by":"crossref","first-page":"7937","DOI":"10.4049\/jimmunol.0803991","article-title":"Increase in ALK1\/ALK5 ratio as a cause for elevated MMP-13 expression in osteoarthritis in humans and mice","volume":"182","author":"Blaney Davidson","year":"2009","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0505","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1136\/ard.2005.045971","article-title":"Expression of transforming growth factor-beta (TGFbeta) and the TGFbeta signalling molecule SMAD-2P in spontaneous and instability-induced osteoarthritis: role in cartilage degradation, chondrogenesis and osteophyte formation","volume":"65","author":"Blaney Davidson","year":"2006","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0510","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.joca.2010.03.001","article-title":"Bone morphogenetic proteins and articular cartilage: to serve and protect or a wolf in sheep clothing's?","volume":"18","author":"van der Kraan","year":"2010","journal-title":"Osteoarthritis and Cartilage"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0515","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/ar2896","article-title":"A role for age-related changes in TGFbeta signaling in aberrant chondrocyte differentiation and osteoarthritis","volume":"12","author":"van der Kraan","year":"2010","journal-title":"Arthritis Research and Therapy"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0520","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/03009740701774941","article-title":"Relationship of bone morphogenetic proteins to disease activity and radiographic damage in patients with ankylosing spondylitis","volume":"37","author":"Park","year":"2008","journal-title":"Scandinavian Journal of Rheumatology"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0525","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3899\/jrheum.090167","article-title":"Peripheral blood expression profiles of bone morphogenetic proteins, tumor necrosis factor-superfamily molecules, and transcription factor Runx2 could be used as markers of the form of arthritis, disease activity, and therapeutic responsiveness","volume":"37","author":"Grcevic","year":"2010","journal-title":"Journal of Rheumatology"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0530","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/art.11389","article-title":"Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis","volume":"48","author":"Lories","year":"2003","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0535","doi-asserted-by":"crossref","first-page":"R58","DOI":"10.1186\/ar1923","article-title":"Decrease in expression of bone morphogenetic proteins 4 and 5 in synovial tissue of patients with osteoarthritis and rheumatoid arthritis","volume":"8","author":"Bramlage","year":"2006","journal-title":"Arthritis Research and Therapy"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0540","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1186\/ar2518","article-title":"Dynamic activation of bone morphogenetic protein signaling in collagen-induced arthritis supports their role in joint homeostasis and disease","volume":"10","author":"Daans","year":"2008","journal-title":"Arthritis Research and Therapy"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0545","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/ard.2007.080127","article-title":"Detection, identification and in vivo treatment responsiveness of bone morphogenetic protein (BMP)-activated cell populations in the synovium of patients with rheumatoid arthritis","volume":"68","author":"Verschueren","year":"2009","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0550","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1172\/JCI23738","article-title":"Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis","volume":"115","author":"Lories","year":"2005","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0555","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0560","doi-asserted-by":"crossref","first-page":"8274","DOI":"10.1158\/0008-5472.CAN-05-1891","article-title":"Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism","volume":"65","author":"Dai","year":"2005","journal-title":"Cancer Research"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0565","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0736-0266(02)00095-5","article-title":"Differences in the cytokine profiles associated with prostate cancer cell induced osteoblastic and osteolytic lesions in bone","volume":"21","author":"Lee","year":"2003","journal-title":"Journal of Orthopaedic Research"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0570","first-page":"389","article-title":"Expression of bone morphogenetic proteins in human metastatic prostate and breast cancer","volume":"46","author":"Bobinac","year":"2005","journal-title":"Croatian Medical Journal"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0575","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2353\/ajpath.2007.051276","article-title":"Lack of noggin expression by cancer cells is a determinant of the osteoblast response in bone metastases","volume":"170","author":"Schwaninger","year":"2007","journal-title":"American Journal of Pathology"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0580","doi-asserted-by":"crossref","first-page":"8742","DOI":"10.1158\/0008-5472.CAN-06-2490","article-title":"Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer","volume":"67","author":"Buijs","year":"2007","journal-title":"Cancer Research"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0585","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2353\/ajpath.2007.070168","article-title":"BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo","volume":"171","author":"Buijs","year":"2007","journal-title":"American Journal of Pathology"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0590","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1359\/JBMR.050802","article-title":"Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer","volume":"20","author":"Feeley","year":"2005","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0595","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1359\/jbmr.060706","article-title":"Mixed metastatic lung cancer lesions in bone are inhibited by noggin overexpression and Rank:Fc administration","volume":"21","author":"Feeley","year":"2006","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0600","doi-asserted-by":"crossref","first-page":"e16078","DOI":"10.1371\/journal.pone.0016078","article-title":"The role of the BMP signaling antagonist noggin in the development of prostate cancer osteolytic bone metastasis","volume":"6","author":"Secondini","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0605","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.bone.2010.11.003","article-title":"Combined inhibition of the BMP pathway and the RANK-RANKL axis in a mixed lytic\/blastic prostate cancer lesion","volume":"48","author":"Virk","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0610","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s00223-008-9111-z","article-title":"Influence of factors regulating bone formation and remodeling on bone quality in osteonecrosis of the femoral head","volume":"82","author":"Tingart","year":"2008","journal-title":"Calcified Tissue International"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0615","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/jor.20873","article-title":"Analysis of bone matrix composition and trabecular microarchitecture of the femoral metaphysis in patients with osteonecrosis of the femoral head","volume":"27","author":"Tingart","year":"2009","journal-title":"Journal of Orthopaedic Research"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0620","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1007\/s11999-010-1738-1","article-title":"Emerging ideas: treatment of precollapse osteonecrosis using stem cells and growth factors","volume":"469","author":"Cui","year":"2011","journal-title":"Clinical Orthopaedics and Related Research"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0625","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2106\/JBJS.J.00716","article-title":"Local administration of ibandronate and bone morphogenetic protein-2 after ischemic osteonecrosis of the immature femoral head: a combined therapy that stimulates bone formation and decreases femoral head deformity","volume":"93","author":"Vandermeer","year":"2011","journal-title":"Journal of Bone and Joint Surgery"},{"issue":"Suppl. IV","key":"10.1016\/j.cytogfr.2012.06.003_bib0630","first-page":"540","article-title":"Ambulatory drilling for necrosis of the femoral head: intermediary results of a randomized study evaluating contribution of autologous bone marrow with and without BMP","volume":"93-B","author":"May","year":"2011","journal-title":"Journal of Bone and Joint Surgery, British Volume"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0635","doi-asserted-by":"crossref","first-page":"7599","DOI":"10.1073\/pnas.78.12.7599","article-title":"Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation","volume":"78","author":"Sampath","year":"1981","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0640","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/0955-0674(92)90110-X","article-title":"Regulation of cartilage and bone differentiation by bone morphogenetic proteins","volume":"4","author":"Reddi","year":"1992","journal-title":"Current Opinion in Cell Biology"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0645","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/term.74","article-title":"Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery)","volume":"2","author":"Bessa","year":"2008","journal-title":"Journal of Tissue Engineering and Regenerative Medicine"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0650","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1016\/j.biomaterials.2011.03.063","article-title":"Effects of protein dose and delivery system on BMP-mediated bone regeneration","volume":"32","author":"Boerckel","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0655","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1902\/jop.2002.73.8.925","article-title":"Factors that modulate the effects of bone morphogenetic protein-induced periodontal regeneration: a critical review","volume":"73","author":"King","year":"2002","journal-title":"Journal of Periodontology"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0660","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/j.1525-1594.2009.00988.x","article-title":"The efficacy of bone morphogenetic protein-2 depends on its mode of delivery","volume":"34","author":"La","year":"2010","journal-title":"Artificial Organs"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0665","doi-asserted-by":"crossref","DOI":"10.1111\/j.1525-1594.2011.01420.x","article-title":"The effect of the delivery carrier on the quality of bone formed via bone morphogenetic Protein-2","author":"La","year":"2012","journal-title":"Artificial Organs"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0670","doi-asserted-by":"crossref","DOI":"10.3858\/emm.2012.44.5.039","article-title":"Comparison between heparin-conjugated fibrin and collagen sponge as bone morphogenetic protein-2 carriers for bone regeneration","author":"Yang","year":"2012","journal-title":"Experimental and Molecular Medicine"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0675","doi-asserted-by":"crossref","first-page":"4856","DOI":"10.1016\/j.biomaterials.2005.01.012","article-title":"Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and beta-tricalcium phosphate","volume":"26","author":"Takahashi","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0680","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-2474-12-44","article-title":"Genetic predisposition to fracture non-union: a case control study of a preliminary single nucleotide polymorphisms analysis of the BMP pathway","volume":"12","author":"Dimitriou","year":"2011","journal-title":"BMC Musculoskeletal Disorders"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0685","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3171\/2009.6.SPINE08669","article-title":"Osteoinductive bone graft substitutes for lumbar fusion: a systematic review","volume":"11","author":"Agarwal","year":"2009","journal-title":"Journal of Neurosurgery: Spine"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0690","first-page":"CD006950","article-title":"Bone morphogenetic protein (BMP) for fracture healing in adults","author":"Garrison","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0695","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/BRS.0b013e3181952695","article-title":"Short-term osteoclastic activity induced by locally high concentrations of recombinant human bone morphogenetic protein-2 in a cancellous bone environment","volume":"34","author":"Toth","year":"2009","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0700","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.injury.2010.11.016","article-title":"Bone morphogenetic proteins in orthopaedic trauma surgery","volume":"42","author":"Argintar","year":"2011","journal-title":"Injury"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0705","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/jor.21165","article-title":"Intra-articular injections of bone morphogenetic protein-7 retard progression of existing cartilage degeneration","volume":"28","author":"Hayashi","year":"2010","journal-title":"Journal of Orthopaedic Research"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0710","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/1471-2474-11-232","article-title":"Phase 1 safety and tolerability study of BMP-7 in symptomatic knee osteoarthritis","volume":"11","author":"Hunter","year":"2010","journal-title":"BMC Musculoskeletal Disorders"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0715","doi-asserted-by":"crossref","first-page":"25509","DOI":"10.1074\/jbc.M513276200","article-title":"Systemically administered bone morphogenetic protein-6 restores bone in aged ovariectomized rats by increasing bone formation and suppressing bone resorption","volume":"281","author":"Simic","year":"2006","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0720","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.bone.2011.05.003","article-title":"Effects of intermittent parathyroid hormone treatment on osteoprogenitor cells in postmenopausal women","volume":"49","author":"Drake","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0725","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1172\/JCI2799","article-title":"Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone","volume":"102","author":"Weinstein","year":"1998","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0730","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1055\/s-0029-1220684","article-title":"Inhibition of the mevalonate pathway rescues the dexamethasone-induced suppression of the mineralization in osteoblasts via enhancing bone morphogenetic protein-2 signal","volume":"41","author":"Kanazawa","year":"2009","journal-title":"Hormone and Metabolic Research"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0735","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bbrc.2008.12.035","article-title":"BMP\/Wnt antagonists are upregulated by dexamethasone in osteoblasts and reversed by alendronate and PTH: potential therapeutic targets for glucocorticoid-induced osteoporosis","volume":"379","author":"Hayashi","year":"2009","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0740","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.286.5446.1946","article-title":"Stimulation of bone formation in vitro and in rodents by statins","volume":"286","author":"Mundy","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0745","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbrc.2005.10.187","article-title":"Simvastatin enhances bone morphogenetic protein receptor type II expression","volume":"339","author":"Hu","year":"2006","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0750","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/gme.0b013e3181d3e036","article-title":"Statins and bone health in postmenopausal women: a systematic review of randomized controlled trials","volume":"17","author":"Yue","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0755","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-11-0132","article-title":"Osteoblasts in osteoporosis: past, emerging, and future anabolic targets","volume":"165","author":"Marie","year":"2011","journal-title":"European Journal of Endocrinology\/European Federation of Endocrine Societies"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0760","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jbspin.2011.02.002","article-title":"Oxytocin and bone remodelling: relationships with neuropituitary hormones, bone status and body composition","volume":"78","author":"Breuil","year":"2011","journal-title":"Joint, Bone, Spine"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0765","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.1073\/pnas.0901890106","article-title":"Oxytocin is an anabolic bone hormone","volume":"106","author":"Tamma","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0770","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1634\/stemcells.2008-0127","article-title":"Oxytocin controls differentiation of human mesenchymal stem cells and reverses osteoporosis","volume":"26","author":"Elabd","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0775","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/jbmr.21","article-title":"Osthole stimulates osteoblast differentiation and bone formation by activation of beta-catenin-BMP signaling","volume":"25","author":"Tang","year":"2010","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0780","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.bbrc.2011.01.021","article-title":"Psoralen stimulates osteoblast differentiation through activation of BMP signaling","volume":"405","author":"Tang","year":"2011","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0785","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.phrs.2008.08.008","article-title":"Anabolic activity of ursolic acid in bone: stimulating osteoblast differentiation in vitro and inducing new bone formation in vivo","volume":"58","author":"Lee","year":"2008","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0790","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2006.08.073","article-title":"Piceatannol stimulates osteoblast differentiation that may be mediated by increased bone morphogenetic protein-2 production","volume":"551","author":"Chang","year":"2006","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0795","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/mnfr.200800483","article-title":"Syringetin, a flavonoid derivative in grape and wine, induces human osteoblast differentiation through bone morphogenetic protein-2\/extracellular signal-regulated kinase 1\/2 pathway","volume":"53","author":"Hsu","year":"2009","journal-title":"Molecular Nutrition & Food Research"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0800","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ejphar.2008.04.030","article-title":"Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos\/c-Jun and AP-1 pathway in osteoblasts","volume":"588","author":"Wu","year":"2008","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0805","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/nm.1888","article-title":"BMP type I receptor inhibition reduces heterotopic [corrected] ossification","volume":"14","author":"Yu","year":"2008","journal-title":"Nature Medicine"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0810","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2106\/00004623-200401000-00013","article-title":"Retroviral delivery of Noggin inhibits the formation of heterotopic ossification induced by BMP-4, demineralized bone matrix, and trauma in an animal model","volume":"86-A","author":"Hannallah","year":"2004","journal-title":"Journal of Bone and Joint Surgery"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0815","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1517\/14728220802637725","article-title":"Targeting bone morphogenetic protein antagonists: in vitro and in vivo evidence of their role in bone metabolism","volume":"13","author":"Tsialogiannis","year":"2009","journal-title":"Expert Opinion on Therapeutic Targets"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0820","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1507\/endocrj.KR-110","article-title":"Signal transduction pathway through activin receptors as a therapeutic target of musculoskeletal diseases and cancer","volume":"55","author":"Tsuchida","year":"2008","journal-title":"Endocrine Journal"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0825","doi-asserted-by":"crossref","first-page":"7082","DOI":"10.1073\/pnas.0711263105","article-title":"A soluble activin type IIA receptor induces bone formation and improves skeletal integrity","volume":"105","author":"Pearsall","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0830","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.bone.2010.01.370","article-title":"A soluble activin receptor Type IIA fusion protein (ACE-011) increases bone mass via a dual anabolic-antiresorptive effect in Cynomolgus monkeys","volume":"46","author":"Lotinun","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0835","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1359\/jbmr.081208","article-title":"Single-dose, randomized, double-blind, placebo-controlled study of ACE-011 (ActRIIA-IgG1) in postmenopausal women","volume":"24","author":"Ruckle","year":"2009","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0885","article-title":"Activin receptor signaling: a potential therapeutic target for osteoporosis","author":"Lotinun","year":"2011","journal-title":"Current Molecular Pharmacology"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0845","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1172\/JCI16198","article-title":"Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro","volume":"111","author":"Garrett","year":"2003","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0890","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2011.12.007","article-title":"Impact of bortezomib on bone health in myeloma: a review of current evidence","author":"Zangari","year":"2012","journal-title":"Cancer Treatment Reviews"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0855","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1210\/jc.2009-2677","article-title":"Update in new anabolic therapies for osteoporosis","volume":"95","author":"Canalis","year":"2010","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0860","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bbrc.2011.03.003","article-title":"Lactacystin, a proteasome inhibitor, enhances BMP-induced osteoblastic differentiation by increasing active Smads","volume":"407","author":"Ito","year":"2011","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.cytogfr.2012.06.003_bib0865","doi-asserted-by":"crossref","first-page":"e26402","DOI":"10.1371\/journal.pone.0026402","article-title":"Designer TGF\u03b2 superfamily ligands with diversified functionality","volume":"6","author":"Allendorph","year":"2011","journal-title":"PLoS ONE"}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610112000421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610112000421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T07:42:21Z","timestamp":1714117341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610112000421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":173,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S1359610112000421"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2012.06.003","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}